AbbVie (ABBV) Shares Outstanding: History & Chart

AbbVie Inc. (ABBV)ABBVAbbVie Inc.

About AbbVie Inc.

AbbVie Inc. is a global biopharmaceutical company dedicated to the discovery, development, manufacturing, and commercialization of advanced medicines. Its extensive therapeutic portfolio encompasses several key areas: Immunology and Inflammation: Leading products include HUMIRA, an injectable therapy for autoimmune and intestinal Behçet's diseases; SKYRIZI, which addresses moderate to severe plaque psoriasis in adults; and RINVOQ, a JAK inhibitor for moderate to severe active rheumatoid arthritis in adult patients. Oncology and Hematology: For blood cancers, AbbVie provides IMBRUVICA and VENCLEXTA (a BCL-2 inhibitor), both indicated for adult patients with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). Virology: MAVYRET offers a treatment option for individuals with chronic HCV genotype 1-6 infection. Gastroenterology and Endocrinology: The company supplies CREON, an enzyme replacement therapy for exocrine pancreatic insufficiency, and Synthroid, used to manage hypothyroidism. Linzess/Constella helps treat irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation. Women's Health and Urology: Lupron serves as a palliative treatment for conditions like advanced prostate cancer, endometriosis, central precocious puberty, and anemia caused by uterine fibroids. ORILISSA, a nonpeptide small molecule GnRH antagonist, is designed for women experiencing moderate to severe endometriosis pain. Neurology: AbbVie offers Duopa and Duodopa, a levodopa-carbidopa intestinal gel for Parkinson's disease, and Ubrelvy to treat migraines (with or without aura) in adults. The therapeutic formulation of Botox is also part of its offerings. Ophthalmology: Its eye care segment features Lumigan/Ganfort (a bimatoprost ophthalmic solution) and Alphagan/Combigan (an alpha-adrenergic receptor agonist), both aimed at reducing elevated intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) or ocular hypertension. Restasis, a calcineurin inhibitor immunosuppressant, is provided to enhance tear production, alongside other specialized eye care products. AbbVie Inc. also engages in research collaborations, including a partnership with Dragonfly Therapeutics, Inc. The company was founded in 2012 and operates from its headquarters in North Chicago, Illinois.

North Chicago, IL

57,000 employees

www.abbvie.com

Healthcare / Drug Manufacturers - General

Sector: Healthcare
Industry: Drug Manufacturers - General
CEO: Robert A. Michael

View full financials

ABBV Shares Outstanding Metrics

SHARES OUTSTANDING

1.77B

SHARES OUTSTANDING AVG TTM

1.77B

SHARES OUTSTANDING AVG 3Y

1.77B

SHARES OUTSTANDING AVG 5Y

1.77B

SHARES OUTSTANDING AVG 10Y

1.68B

SHARES OUTSTANDING AVG 15Y

1.66B

SHARES OUTSTANDING AVG 20Y

N/A

CURRENT VS TTM AVG

+0.07%

CURRENT VS 3Y AVG

+0.10%

CURRENT VS 5Y AVG

-0.01%

CURRENT VS 10Y AVG

+5.46%

CURRENT VS 15Y AVG

+6.97%

CURRENT VS 20Y AVG

N/A

Period	Weighted Average Shares	QoQ Change
Quarter ended Mar 2026	1.77B	+0.00%
Quarter ended Dec 2025	1.77B	+0.11%
Quarter ended Sep 2025	1.77B	+0.00%
Quarter ended Jun 2025	1.77B	+0.00%

Period

Weighted Average Shares

QoQ Change

Quarter ended Mar 2026

1.77B

+0.00%

Quarter ended Dec 2025

1.77B

+0.11%

Quarter ended Sep 2025

1.77B

+0.00%

Quarter ended Jun 2025

1.77B

+0.00%

Shares Outstanding FAQ

What is the shares outstanding for AbbVie Inc. (ABBV)?

The shares outstanding for ABBV stock is 1.77B.

What is the TTM average shares outstanding for AbbVie Inc. (ABBV)?

The TTM average shares outstanding for ABBV stock is 1.77B.

What is the 3Y average shares outstanding for AbbVie Inc. (ABBV)?

The 3Y average shares outstanding for ABBV stock is 1.77B.

What is the 5Y average shares outstanding for AbbVie Inc. (ABBV)?

The 5Y average shares outstanding for ABBV stock is 1.77B.

What is the 10Y average shares outstanding for AbbVie Inc. (ABBV)?

The 10Y average shares outstanding for ABBV stock is 1.68B.

What is the 15Y average shares outstanding for AbbVie Inc. (ABBV)?

The 15Y average shares outstanding for ABBV stock is 1.66B.

DATE	SHARES OUTSTANDING
2026-03-31	1.77B
2025-12-31	1.77B
2025-09-30	1.77B
2025-06-30	1.77B
2025-03-31	1.77B
2024-12-31	1.77B
2024-09-30	1.77B
2024-06-30	1.77B
2024-03-31	1.77B
2023-12-31	1.77B
2023-09-30	1.77B
2023-06-30	1.77B
2023-03-31	1.78B
2022-12-31	1.78B
2022-09-30	1.78B
2022-06-30	1.78B
2022-03-31	1.78B
2021-12-31	1.78B
2021-09-30	1.78B
2021-06-30	1.78B
2021-03-31	1.77B
2020-12-31	1.78B
2020-09-30	1.77B
2020-06-30	1.65B
2020-03-31	1.48B
2019-12-31	1.49B
2019-09-30	1.48B
2019-06-30	1.48B
2019-03-31	1.48B
2018-12-31	1.48B
2018-09-30	1.51B
2018-06-30	1.57B
2018-03-31	1.60B
2017-12-31	1.60B
2017-09-30	1.60B
2017-06-30	1.60B
2017-03-31	1.60B
2016-12-31	1.62B
2016-09-30	1.64B
2016-06-30	1.63B
2016-03-31	1.63B
2015-12-31	1.64B
2015-09-30	1.66B
2015-06-30	1.63B
2015-03-31	1.61B
2014-12-31	1.60B
2014-09-30	1.61B
2014-06-30	1.61B
2014-03-31	1.61B
2013-12-31	1.61B
2013-09-30	1.60B
2013-06-30	1.61B
2013-03-31	1.60B
2012-12-31	1.60B
2012-09-30	1.58B
2012-06-30	1.63B
2012-03-31	1.63B
2011-12-31	1.58B
2011-09-30	1.58B
2011-06-30	1.58B
2011-03-31	1.63B

DATE

SHARES OUTSTANDING

2026-03-31

1.77B

2025-12-31

1.77B

2025-09-30

1.77B

2025-06-30

1.77B

2025-03-31

1.77B

2024-12-31

1.77B

2024-09-30

1.77B

2024-06-30

1.77B

2024-03-31

1.77B

2023-12-31

1.77B

2023-09-30

1.77B

2023-06-30

1.77B

2023-03-31

1.78B

2022-12-31

1.78B

2022-09-30

1.78B

2022-06-30

1.78B

2022-03-31

1.78B

2021-12-31

1.78B

2021-09-30

1.78B

2021-06-30

1.78B

2021-03-31

1.77B

2020-12-31

1.78B

2020-09-30

1.77B

2020-06-30

1.65B

2020-03-31

1.48B

2019-12-31

1.49B

2019-09-30

1.48B

2019-06-30

1.48B

2019-03-31

1.48B

2018-12-31

1.48B

2018-09-30

1.51B

2018-06-30

1.57B

2018-03-31

1.60B

2017-12-31

1.60B

2017-09-30

1.60B

2017-06-30

1.60B

2017-03-31

1.60B

2016-12-31

1.62B

2016-09-30

1.64B

2016-06-30

1.63B

2016-03-31

1.63B

2015-12-31

1.64B

2015-09-30

1.66B

2015-06-30

1.63B

2015-03-31

1.61B

2014-12-31

1.60B

2014-09-30

1.61B

2014-06-30

1.61B

2014-03-31

1.61B

2013-12-31

1.61B

2013-09-30

1.60B

2013-06-30

1.61B

2013-03-31

1.60B

2012-12-31

1.60B

2012-09-30

1.58B

2012-06-30

1.63B

2012-03-31

1.63B

2011-12-31

1.58B

2011-09-30

1.58B

2011-06-30

1.58B

2011-03-31

1.63B

Shares Outstanding: 1.77B

ABBV Shares Outstanding

ABBV Average Shares Outstanding Chart

ABBV Current vs Average Shares Outstanding Chart

ABBV Shares Outstanding Metrics

Share Structure

Quarterly Shares Outstanding History

Shares Outstanding Formula & Definition

Shares Outstanding FAQ

ABBV Shares Outstanding History

Related Metrics